Check out what's clicking on FoxBusiness.com.
A popular brand of eye drops Called all over the country According to the Food and Drug Administration (FDA) due to possible contamination, which may cause vision damage.
On Monday, the FDA announced that Texas-based Alcon Laboratories is voluntarily recalling a large number of Systane Eye Drops Ultra SPF, Single Vials On-the-Go because the products may be contaminated with fungus.
The company reported a consumer complaint that a “foreign material” was found inside a sealed single-use vial and determined that the material was “fungal in nature.”
Fungal contamination is known in eye productso Potentially cause eye infection, the FDA said.
Eye products sold at Walmart, CVs can pose a risk of infection
Texas-based Alcon Laboratories is voluntarily recalling large quantities of Systane Ultra SPF Lubricating Eye Drops, Single Vials On-the-Go because the products may have been contaminated with entertainment, the FDA announced Monday. have been (Food and Drug Organization (FDA) / Fox News)
If an infection occurs, the FDA said, it can be vision-threatening, and in very rare cases is potentially life-threatening in immunocompromised patients.
To date, the FDA said Alcon Laboratories has not received any reports of adverse events related to the recall.
FDA says the affected product consists of Systane Ultra PF Lubricating Eye Drops, single vial in motion, count of 25, and is limited to lot number 10101, expiration date 09/2025.
The FDA explained in a press release that the product can be identified by the green and pink carton design, the presence of the trade names “Systane” and “ULTRA PF” on the front of the carton, and the “25 vial” package size.
FDA Raises Costco Egg Recall to Highest Risk Level Over Salmonella Fears
Systane Ultra SPF Lubricant Eye Drops, Single Vials On-the-Go are being recalled because the products may be contaminated with fungus, according to the FDA. (Food and Drug Organization (FDA) / Fox News)
Many potentially affected eye drops were also distributed across the country in retail and online stores.
Consumers who have the recalled eye drops are urged to stop using them immediately and return them to the place of purchase for a replacement or refund, the FDA said.
Distributors or retailers who have the recalled eye drops are also asked to dispose of any remaining stock of the contaminated product.
Alcon Laboratories is also notifying its distributors and customers by letter, email and/or telephone and is making arrangements to replace all recalled products.
Alcon Laboratories issued the recall after a consumer complained of “foreign material” they found in a sealed bottle of eye drops. (Food and Drug Organization (FDA) / Fox News)
This latest recall comes as several eye products have been pulled from the shelves over the past year due to the potential risk of infection.
In February, eye ointment products will be sold CVS and Walmart stores nationwide They were recalled after the FDA found a “sterility failure” at the manufacturing facility.
Alcon Laboratories in Texas is voluntarily recalling Systane Lubricant Eye Drops Ultra PF following consumer complaints of foreign material that can be seen inside a sealed vial. (Food and Drug Organization (FDA) / Fox News Latino)
The four affected products, which are considered sterile, are sold under the brand names Equate, CVS Health and AACE Pharmaceuticals and have expiration dates from February 2024 to September 2025. Products nationwide to wholesalers, retailers and through the product distributor, Walmart, CVS and AACE Pharmaceuticals Inc.
Get FOX Business on the Move by clicking here
In November 2023, Kilitch Healthcare India Limited voluntarily recalled 27 eye drops, all of which were listed on the FDA's list of products that may be contaminated with bacteria and pose a risk of eye infection and vision loss.
None of the above recalls have been linked to outbreaks of antibiotic-resistant bacteria. Pseudomonas aeruginosa Related eye products by Global Pharma Healthcare.
Fox News Digital's Daniella Genovese contributed to this report.